RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GRIGUOLO D
Collezione AO Ordine Mauriziano

Items : 3

Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents. in American journal of hematology / Am J Hematol. 2025 Apr;100(4):708-711. doi: 10.1002/ajh.27591. Epub 2025 Jan 20.

2025
AO Ordine Mauriziano

Marconi G; Petracci E; Lanzarone G; Vetro C; Martelli MP; Papayannidis C; Audisio E; Minetto P; Riva C; Guolo F; Martini G; Zappasodi P; Vincenzo F; Gigli F; Griguolo D; Rondoni M; Ciotti G; Borlenghi E; Ciccone N; Palumbo FE; Nanni J; Mattei D; Bernardi M; Cignetti A; Zingaretti C; Vertogen B; Cerchione C; Lanza F; Cilloni D; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano

Della Porta MG; Santini V; Pasini P; Naldi I; Giordano L; Finelli C; Turrini M; Tosi P; Selleri C; Tanasi I; Sancetta R; Norata M; Frigeni M; Marchetti M; Grimaldi D; Galimberti S; Fianchi L; Ferrara F; Di Veroli A; Di Bona E; Calvisi A; Castelli A; Bono R; Occhini U; Rivoli G; Nicolino B; Molteni A; Guarini A; Genua A; et alii...

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano

Gigli F; Cardinali V; Romano A; Nanni J; Maurillo L; Ferrara F; Rivellini F; Cascavilla N; Abruzzese E; Lanza F; Cilloni D; Fianchi L; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Manfra I; Basilico CM; Facchini L; Rizzuto G; Fumagalli M; Bernardi M; Mattei D; Selleri C; Cerchione C; Griguolo D; et alii...